Detalhe da pesquisa
1.
Effectiveness, Durability, and Safety of Dolutegravir and Lamivudine Versus Dolutegravir, Lamivudine, and Abacavir in a Real-Life Cohort of HIV-Infected Adults.
Ann Pharmacother
; 56(4): 412-421, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34293960
2.
Deprescribing of non-antiretroviral therapy in HIV-infected patients.
Eur J Clin Pharmacol
; 76(3): 305-318, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31865412
3.
HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolution.
Cell Immunol
; 286(1-2): 31-8, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24287274
4.
Effectiveness, durability and safety of dolutegravir and lamivudine versus bictegravir, emtricitabine and tenofovir alafenamide in a real-world cohort of HIV-infected adults.
PLoS One
; 18(9): e0291480, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37773939
5.
Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab.
Clin Transl Oncol
; 10(9): 587-90, 2008 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-18796377
6.
Adaptive immune response during hepatitis C virus infection.
World J Gastroenterol
; 20(13): 3418-30, 2014 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-24707125
7.
Intervention for control of hypertension in Catalonia, Spain (INCOTECA Project): results of a multicentric, non-randomised, quasi-experimental controlled intervention study.
BMJ Open
; 2(2): e000507, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22514242